Nu-Med Plus Announces the Addition of Mark Christensen M.Pr.A., C.P.A. as Chief Financial Officer

SALT LAKE CITY, UT--(Marketwired - Apr 21, 2015) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the selection of Mark Christensen as their Chief financial Officer.

Mr. Christensen has been an active licensed C.P.A. for over 25 years. He has several years of experience with the international accounting firm KPMG Peat Marwick and as a partner in Bushman, Miyasaki & Associates and Stewart & Christensen, LLC. Mr. Christensen has provided services to a wide range of industries and businesses. He has also provided strategic planning and support services for numerous client company formations, restructurings, sales and acquisitions. Mr. Christensen graduated Cum Laude from the University of Utah and holds an M.Pr.A. in Accounting, a B.A. in Accounting, and a B.A. in Finance. "As NU-MED PLUS continues to grow and expand the addition of Mr. Christensen will benefit us significantly in the corporate financial arena," commented Mr. Jeff Robins, President and CEO of Nu-Med-Plus.

About Nu-Med Plus, Inc.

Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to concentrate on high growth potential markets where there are visible, distinct needs recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use. For more information please visit

Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's ability to complete proposed private placement financing. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.

Contact Information:


Jeff Robins